Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients.
McGovern BH, Ditelberg JS, Taylor LE, Gandhi RT, Christopoulos KA, Chapman S, Schwartzapfel B, Rindler E, Fiorino AM, Zaman MT, Sax PE, Graeme-Cook F, Hibberd PL. McGovern BH, et al. Among authors: christopoulos ka. Clin Infect Dis. 2006 Aug 1;43(3):365-72. doi: 10.1086/505495. Epub 2006 Jun 22. Clin Infect Dis. 2006. PMID: 16804853
The Association of HIV Control and Immunosuppression With Risk of Non-AIDS-Defining Cancer Risk Among Patients on Antiretroviral Therapy.
Dickey BL, Yanik EL, Thompson Z, Burkholder G, Kitahata MM, Moore RD, Jacobson J, Mathews WC, Christopoulos KA, Fleming J, Napravnik S, Achenbach C, Coghill AE. Dickey BL, et al. Among authors: christopoulos ka. J Acquir Immune Defic Syndr. 2024 Mar 1;95(3):275-282. doi: 10.1097/QAI.0000000000003350. J Acquir Immune Defic Syndr. 2024. PMID: 37977197
Clinical and Behavioral Outcomes for Transgender Women Engaged in HIV Care: Comparisons to Cisgender Men and Women in the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) Cohort.
Reisner SL, Whitney BM, Crane HM, Mayer KH, Grasso C, Nance RM, Poteat T, Mathews WC, Christopoulos K, Mugavero MJ, Chander G, Eron JJ, Kitahata MM, Delaney JAC, Fredericksen RJ. Reisner SL, et al. AIDS Behav. 2023 Jul;27(7):2113-2130. doi: 10.1007/s10461-022-03947-4. Epub 2023 Jan 6. AIDS Behav. 2023. PMID: 36609705 Free PMC article.
A factorial experiment grounded in the multiphase optimization strategy to promote viral suppression among people who inject drugs on the Texas-Mexico border: a study protocol.
Sauceda JA, Lechuga J, Ramos ME, Puentes J, Ludwig-Barron N, Salazar J, Christopoulos KA, Johnson MO, Gomez D, Covarrubias R, Hernandez J, Montelongo D, Ortiz A, Rojas J, Ramos L, Avila I, Gwadz MV, Neilands TB. Sauceda JA, et al. Among authors: christopoulos ka. BMC Public Health. 2023 Feb 10;23(1):307. doi: 10.1186/s12889-023-15172-2. BMC Public Health. 2023. PMID: 36765309 Free PMC article.
Alcohol and drug use severity are independently associated with antiretroviral adherence in the current treatment era.
Ma J, Luu B, Ruderman SA, Whitney BM, Merrill JO, Mixson LS, Nance RM, Drumright LN, Hahn AW, Fredericksen RJ, Chander G, Lau B, McCaul ME, Safren S, O'Cleirigh C, Cropsey K, Mayer KH, Mathews WC, Moore RD, Napravnik S, Christopoulos K, Willig A, Jacobson JM, Webel A, Burkholder G, Mugavero MJ, Saag MS, Kitahata MM, Crane HM, Delaney JAC. Ma J, et al. AIDS Care. 2024 May;36(5):618-630. doi: 10.1080/09540121.2023.2223899. Epub 2023 Jul 7. AIDS Care. 2024. PMID: 37419138
Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People With HIV Who Are Virally Unsuppressed.
Hickey MD, Grochowski J, Mayorga-Munoz F, Oskarsson J, Imbert E, Spinelli M, Szumowski JD, Appa A, Koester K, Dauria EF, McNulty M, Colasanti J, Havlir DV, Gandhi M, Christopoulos KA. Hickey MD, et al. Among authors: christopoulos ka. J Acquir Immune Defic Syndr. 2024 Jul 1;96(3):280-289. doi: 10.1097/QAI.0000000000003421. J Acquir Immune Defic Syndr. 2024. PMID: 38534179
Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020.
Shapiro AE, Bender Ignacio RA, Whitney BM, Delaney JA, Nance RM, Bamford L, Wooten D, Keruly JC, Burkholder G, Napravnik S, Mayer KH, Webel AR, Kim HN, Van Rompaey SE, Christopoulos K, Jacobson J, Karris M, Smith D, Johnson MO, Willig A, Eron JJ, Hunt P, Moore RD, Saag MS, Mathews WC, Crane HM, Cachay ER, Kitahata MM; CFAR Network of Integrated Clinical Systems. Shapiro AE, et al. medRxiv [Preprint]. 2021 Oct 18:2021.10.15.21265063. doi: 10.1101/2021.10.15.21265063. medRxiv. 2021. Update in: J Acquir Immune Defic Syndr. 2022 Aug 1;90(4):369-376. doi: 10.1097/QAI.0000000000002989 PMID: 34704092 Free PMC article. Updated. Preprint.
134 results